Dr. Alan Kerr
D. Alan Kerr II, MD, PHD

Dr. D. Alan Kerr is a hematologist-oncologist and physician scientist with Tampa General Hospital, where he previously conducted continuity clinic work with a focus on malignant hematology. He specializes in benign and malignant hematology as well as solid tumor oncology.

Prior to joining Tampa General, Dr. Kerr treated patients in a private community practice at Advanced Cancer Treatment Centers (ACTC) in Brooksville, Fla., after completing a three-year hematology and medical oncology fellowship program with Moffitt Cancer Center/University of South Florida. Before that, he completed an internal medicine residency program at the University of Louisville in Kentucky, where he served as a chief medical resident. In the same department, he followed his passion for teaching future medical professionals as an assistant professor from 2015-16. Dr. Kerr received his medical degree from the University of Louisville School of Medicine and holds a Ph.D. in biochemistry and molecular biology from the University of Louisville.

Dr. Kerr is a site investigator for numerous active clinical trials and his primary clinical interests include lymphomas and myeloid diseases. Well-versed in translational research and clinical research protocols, Dr. Kerr is credited with several publications, oral presentations and abstracts on a wide range of oncology topics. He is a diplomat of the American Board of Internal Medicine and has memberships with the American Society of Clinical Oncology and the American Society of Hematology.

American Board of Internal Medicine – Internal Medicine, Hematology, Medical Oncology

Blood clotting/bleeding disorders

Solid tumors

Procedures Offered:
Bone marrow biopsies
Intrathecal chemo infusions

University of Louisville School of Medicine (Louisville, Ky.)

University of Louisville (Louisville, Ky.)

Internal Medicine
University of Louisville (Louisville, Ky.)

Hematology and Medical Oncology
Moffitt Cancer Center/University of South Florida (Tampa, Fla.)

Share This